<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03914339</url>
  </required_header>
  <id_info>
    <org_study_id>meenu ortho</org_study_id>
    <nct_id>NCT03914339</nct_id>
  </id_info>
  <brief_title>Effect of Orthodontic Treatment on Periodontally Compromised Dentition- Randomised Control Trial</brief_title>
  <official_title>&quot;EFFECT OF ORTHODONTIC TREATMENT ON PERIODONTAL HEALTH OF PERIODONTALLY COMPROMISED DENTITION- A Prospective Randomized Controlled Clinical Trial&quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Postgraduate Institute of Dental Sciences Rohtak</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Postgraduate Institute of Dental Sciences Rohtak</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main aim of this prospective, randomized controlled clinical study is to:

      • To evaluate and compare the effect of a combined orthodontic -periodontal treatment
      protocol versus periodontal treatment alone on osseous and non -osseous parameters in
      periodontally compromised patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All the patients of both the groups will receive a detailed periodontal evaluation and then
      therapeutic management of patients will be done as per their periodontal requirement. This
      will include oral hygiene instruction, scaling and root planning and re-evaluation after 2
      weeks and periodontal surgical treatment if indicated will be re-evaluated 4-6 weeks. After
      an observation period of 2 months confirming patient cooperation and their ability to
      maintain good oral hygiene as well as stability of the periodontal results orthodontic
      treatment will be started in the test group whereas the control group will be kept on monthly
      recall for the first 3 months and then every 3 months as per the oral hygiene status
      requirement of the patient.periodontal charting will be done at every 3 months till finish of
      treatment and supra gingival scaling will be provided as per requirement in both the
      groups.Changes in periodontal status in terms of clinical and radiographic parameters will be
      compared between the groups. cone beam Computed tomography will be taken at the baseline T0
      and study end point T2 for assessment of changes in the bone level around maxillary and
      mandibular teeth
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2018</start_date>
  <completion_date type="Anticipated">April 2020</completion_date>
  <primary_completion_date type="Anticipated">April 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>• Alveolar crest bone level</measure>
    <time_frame>12 months</time_frame>
    <description>measured from Cemento- enamel junction to bone crest.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical attachment level (CAL).</measure>
    <time_frame>12 months</time_frame>
    <description>• pocket to cemento- enamel junction .</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Periodontal Bone Loss</condition>
  <arm_group>
    <arm_group_label>Test group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Eighteen periodontally compromised patients who will be given both orthodontic and periodontal treatment .</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Eighteen periodontally compromised patients will receive periodontal treatment alone .</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Periodontal and orthodontic treatment</intervention_name>
    <description>Eighteen periodontally compromised patients who give be given both periodontal and orthodontic treatment</description>
    <arm_group_label>Test group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>periodontal treatment</intervention_name>
    <description>Eighteen periodontally compromised patients who give be given periodontal treatment alone.</description>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

        .• Patient age criteria 20-40 years.

          -  Periodontally Compromised dentition with moderate to severe periodontitis ≥2 teeth
             with pocket depth (PD) ≥5 mm and loss of clinical attachment level (CAL) ≥ 4mm. and
             radiographic bone loss

          -  Good general health status.

          -  Malocclusion that needs orthodontic treatment

        Exclusion Criteria:

          -  Systemic illness known to affect the periodontium or outcome of periodontal and
             orthodontic therapy.

          -  Patient taking medications such as corticosteroids or calcium channel blockers, which
             are known to interfere periodontal wound healing or patient on long term NSAID
             therapy.

          -  Pregnant or lactating women.

          -  Smokers(≥5 cigarettes∕ day).

          -  Noncompliance to oral hygiene measures after Phase I therapy.

          -  Presence of trauma from occlusion (TFO).

          -  Patients with aggressive periodontitis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rekha sharma, MDS</last_name>
    <role>Study Chair</role>
    <affiliation>PGIDS,ROHTAK</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rekha sharma, MDS</last_name>
    <phone>8076190296</phone>
    <email>rajsringari@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>meenu gehlot, BDS</last_name>
    <phone>8901329882</phone>
    <email>meenugehlot82@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Pgids,Rohtak</name>
      <address>
        <city>Rohtak</city>
        <state>Haryana</state>
        <zip>124001</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>REKHA SHARMA, MDS</last_name>
      <phone>8076190296</phone>
      <email>rajsringari@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>meenu gehlot, BDS</last_name>
      <phone>8901329882</phone>
      <email>meenugehlot82@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>PGIDS</name>
      <address>
        <city>Rohtak</city>
        <state>Haryana</state>
        <zip>124001</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rekha sharma, mds</last_name>
      <phone>8076190296</phone>
      <email>rajsringari@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>meenu gehlot, BDS</last_name>
      <phone>8901329882</phone>
      <email>meenugehlot82@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>April 11, 2019</study_first_submitted>
  <study_first_submitted_qc>April 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 16, 2019</study_first_posted>
  <last_update_submitted>April 11, 2019</last_update_submitted>
  <last_update_submitted_qc>April 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alveolar Bone Loss</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

